Recombinant FCRL5 (Cevostamab Biosimilar) antibody (PE)

Catalog No. ABIN7829154

The PE-conjugated Humanized Monoclonal anti-FCRL5 (Cevostamab Biosimilar) antibody (ABIN7829154) specifically detects FCRL5 (Cevostamab Biosimilar) in FACS. The antibody is reactive with Human samples.

Quick Overview for Recombinant FCRL5 (Cevostamab Biosimilar) antibody (PE) (ABIN7829154)

Target: FCRL5 (Cevostamab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This FCRL5 (Cevostamab Biosimilar) antibody is conjugated to PE

Application: Flow Cytometry (FACS)

Grade: Research Grade

Product Details anti-FCRL5 (Cevostamab Biosimilar) Antibody (PE)

Purpose: PE-conjugated Anti-FCRL5(cevostamab biosimilar without anti-CD3 portion) mAb

Isotype: IgG1, kappa

Application Details

Application Notes: Flow Cyt 1:200

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Liquid,PBS with 0.1 % Proclin300, 0.18 % BSA

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment: Store at 2°C-8°C for 6 months

Expiry Date: 6 months

Target Details for FCRL5 (Cevostamab Biosimilar)

Target: FCRL5 (Cevostamab Biosimilar)

Alternative Name: Cevostamab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:BXMAS1,CD307,CD307e,FCRH5,IRTA2,PRO820
Synonyms Antibody:BFCR-4350-A, BFCR-4350A, RG-6160, RO-7187797

UniProt: Q96RD9